The Federal Trade Commission is poised to assess Eli Lilly (LLY) and other drugmakers' ability to secure alternative suppliers amid Novo Nordisk's (NVO) acquisition of Catalent (CTLT) and its plants, potentially raising antitrust concerns if viable alternatives aren't found, as reported by CTFN and Reuters.

Adani Power clarifies submission of resolution plan for Lanco Amarkantak Power acquisition, awaiting communication from Resolution Professional, amidst emerging as winning bidder for Rs 4,101 crore amid Reliance Industries Ltd. and Power Finance Corp. consortium withdrawal from the auction.

CCI approved Zurich Insurance's acquisition of a 70% stake in Kotak Mahindra General Insurance, alongside other transactions involving Interise Investment Managers Limited and Shadowfax Technologies Private Limited.

Australian energy majors Woodside and Santos have ceased discussions on an A$85.7bn ($55.9bn) merger, citing a lack of identified combination benefits and maintaining a disciplined approach to mergers and acquisitions.